Market Tracker

05/22 10:01pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.51
Delayed Data
As of May 22
 -0.07 / -1.25%
Today’s Change
3.78
Today|||52-Week Range
16.90
-2.82%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.58
Today’s open5.60
Day’s range5.47 - 5.75
Volume52,864
Average volume (3 months)245,663
Market cap$131.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+75.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd+0.21+3.34%
LPCNLipocine Inc0.000.00%
SMMTSummit Therapeutics ...+0.18+1.64%
RNNRexahn Pharmaceutica...-0.03-4.00%
Data as of 4:02pm ET, 05/22/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts